Year-over-year earnings per share growth for the last twelve months: Cardiol Therapeutics Inc. (CRDL)

Brandmark of Cardiol Therapeutics Inc (CRDL)

Cardiol Therapeutics (CRDL) develops unique anti-inflammatory agents for rare cardiopathies, which, given the lack of analogues and the existence of patents, promises market leadership, although the testing stage and absence of sales result in negative earnings. The quarterly EPS growth rate on the GURU.Markets terminal chart, where 5.50 is the current value of the indicator, helps assess the trend. Company revenues rely on research grants for the development of cannabidiol-based drugs.

Cardiol Therapeutics Inc (CRDL) Year-over-year earnings per share growth for the last twelve months: for the period 07/04/2022 - 11/16/2026

cardiolrx.com - analytical breakdowns and key metrics (CRDL)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Summary company analytics:Cardiol Therapeutics Inc - CRDL
Finished products of Cardiol Therapeutics

The integration of robotic platforms for high-precision pipetting into Cardiol Therapeutics (CRDL) research directly impacts operational efficiency, which is reflected in the quarterly EPS trend. This metric compares the current period's earnings per share with the same figure from the previous quarter, allowing investors to assess capitalization dynamics and the fundamental stability of the business over the long term.

Analysis of competing companies

Regeneron Pharmaceuticals (REGN) - Year-over-year earnings per share growth for the last twelve months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|LNTH (Lantheus Holdings) - Quarterly EPS earnings growth|Quarterly EPS earnings growth mineralystx.com|Year-over-year earnings per share growth for the last twelve months HeartFlow Inc (HTFL)|KMTS (Kestra Medical Technologies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Esperion Therapeutics ESPR|AMRN - Year-over-year net earnings per share growth for the last 12 months|Anteris Technologies Ltd - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TNYA (tenayatherapeutics.com)|CVRX: Quarterly EPS earnings growth|Milestone Pharmaceuticals, Inc. - Year-over-year earnings per one share growth for the last 12 months|BEAT (HeartBeam Corporation) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Tenax Therapeutics Inc|Quarterly EPS earnings growth ADGM|BioCardia, Inc. - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth VTAK (Catheter Precision Inc)|ABIO - Year-over-year net earnings per share growth for the last 12 months|Acasti Pharma - Quarterly EPS earnings growth|AVTE - Quarterly EPS earnings growth|VERV (vervetx.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share trend for the last twelve months WINT (Windtree Therapeutics Inc.)